Back
CeriBell Vs. Neurogene Industry Stock Comparison
Sell
8
CBLL
CeriBell
Last Price:
26.59
Seasonality Move:
--
Sell
1
NGNE
Neurogene
Last Price:
34.67
Seasonality Move:
50.43%
Sell
8
CeriBell (CBLL)
is a Sell
Is CeriBell a Buy, Sell or Hold?
- The current CeriBell [CBLL] share price is $26.53. The Score for CBLL is 8, which is 84% below its historic median score of 50, and infers higher risk than normal.
- CBLL is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
Sell
1
Neurogene (NGNE)
is a Sell
Is Neurogene a Buy, Sell or Hold?
- The current Neurogene [NGNE] share price is $34.52. The Score for NGNE is 1, which is 98% below its historic median score of 50, and infers higher risk than normal.
- NGNE is currently trading in the 0-10% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk could be especially high.
CBLL Stock Price Chart
CBLL Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 4.06 | Buy |
Relative Strength Index (14 RSI): | 49.8 | Sell |
Chaikin Money Flow: | -106468 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (25.75 - 27.87) | Sell |
Bollinger Bands (100): | ( - ) | Buy |
NGNE Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.55 | Sell |
Relative Strength Index (14 RSI): | 35.74 | Sell |
Chaikin Money Flow: | -452975 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (41.4 - 61.5) | Sell |
Bollinger Bands (100): | (34.32 - 50.52) | Sell |
CBLL Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 28.09 | Sell |
20-day SMA: | 27.06 | Sell |
50-day SMA: | 0 | Buy |
200-day SMA: | 0 | Buy |
8-day EMA: | 27.52 | Sell |
20-day EMA: | 24.86 | Buy |
50-day EMA: | 16.71 | Buy |
200-day EMA: | 5.75 | Buy |
NGNE Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 53.3 | Sell |
20-day SMA: | 51.47 | Sell |
50-day SMA: | 46.76 | Sell |
200-day SMA: | 38.99 | Sell |
8-day EMA: | 47.13 | Sell |
20-day EMA: | 50.2 | Sell |
50-day EMA: | 47.47 | Sell |
200-day EMA: | 38.44 | Sell |
CeriBell Earnings Growth & CBLL Earnings Dates
- Analysts estimate an earnings decrease this quarter of $1.39 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and an increase next year of $0.87 per share.
Neurogene Earnings Growth & NGNE Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.90 per share.
CeriBell Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Neurogene Technical Analysis
Nov 4 | Nov 5 | Nov 6 | Nov 7 | Nov 8 | Nov 11 | Nov 12 | Nov 13 | Nov 14 | Nov 15 | |
---|---|---|---|---|---|---|---|---|---|---|
Nov | ||||||||||
04 | 05 | 06 | 07 | 08 | 11 | 12 | 13 | 14 | 15 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |